1. Home/
  2. Compounds/
  3. BRD-K27188169:navitoclax (2:1 mol/mol)

BRD-K27188169:navitoclax (2:1 mol/mol)


SourcesNames Used
CTRPv2BRD-K27188169:navitoclax (2:1 mol/mol)
PharmacoGx BRD-K27188169:navitoclax (2:1 mol/mol)

Cell lines tested with BRD-K27188169:navitoclax (2:1 mol/mol)

373 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
IGROV-1 ovary CTRPv22
P3HR-1 haematopoietic and lymphoid tissue CTRPv22
CAL-51 breast CTRPv22
NCI-H460 lung CTRPv22
NCI-H1299 lung CTRPv22
SUIT-2 pancreas CTRPv22
A375 skin CTRPv22
ZR-75-1 breast CTRPv21
YAPC pancreas CTRPv21
Download CSV

Tissues tested with BRD-K27188169:navitoclax (2:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv272
large intestineCTRPv227
central nervous systemCTRPv221
urinary tractCTRPv215
Download CSV
Download Data as CSV

Top molecular features associated with response to BRD-K27188169:navitoclax (2:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA BEND5 CTRPv2 AAC 0.39 7e-14
mRNA BCL2 CTRPv2 AAC 0.39 9e-13
mRNA DUSP26 CTRPv2 AAC 0.32 7e-10
mRNA CIC CTRPv2 AAC 0.32 9e-10
mRNA WDR7 CTRPv2 AAC 0.34 2e-09
mRNA GRIK5 CTRPv2 AAC 0.32 2e-09
mRNA PTOV1 CTRPv2 AAC 0.3 3e-09
mRNA ZNF428 CTRPv2 AAC 0.3 4e-09
mRNA HDHD2 CTRPv2 AAC 0.32 1e-08
mRNA STMN1 CTRPv2 AAC 0.29 3e-08
Download CSV